R777-E061 Hs.ERBB2 Citations (1)

Originally described in: Esposito lab
Unpublished

Articles Citing R777-E061 Hs.ERBB2

Articles
HER2 mediates clinical resistance to the KRAS(G12C) inhibitor sotorasib, which is overcome by co-targeting SHP2. Ho CSL, Tuns AI, Schildhaus HU, Wiesweg M, Gruner BM, Hegedus B, Schuler M, Schramm A, Oeck S. Eur J Cancer. 2021 Dec;159:16-23. doi: 10.1016/j.ejca.2021.10.003. Epub 2021 Oct 26. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.